AI assistant
PRECISION BIOSCIENCES INC — Director's Dealing 2022
Sep 9, 2022
34491_dirs_2022-09-09_df443e30-211f-4004-a261-d1e5b4114db3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2022-09-01
Reporting Person: SMITH J. JEFFERSON (Chief Research Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1902474 | Direct |
| Common Stock | 237959 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $1.18 | 2027-03-23 | Common Stock (23422) | Direct | |
| Employee Stock Option (Right to Buy) | $11.98 | 2028-10-11 | Common Stock (46845) | Direct | |
| Employee Stock Option (Right to Buy) | $5.83 | 2030-08-20 | Common Stock (35786) | Direct | |
| Employee Stock Option (Right to Buy) | $11.34 | 2031-06-06 | Common Stock (25118) | Direct | |
| Restricted Stock Units | $ | Common Stock (9744) | Direct | ||
| Employee Stock Option (Right to Buy) | $4.08 | 2032-03-02 | Common Stock (74197) | Direct | |
| Restricted Stock Units | $ | Common Stock (46720) | Direct |
Footnotes
F1: Stock options are fully vested as of the date of this report.
F2: The option vested as to 25% of the underlying shares on September 28, 2019 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
F3: The option vested as to 25% of the underlying shares on April 1, 2021 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
F4: The option vested as to 25% of the underlying shares on June 7, 2022 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
F5: The restricted stock units ("RSUs") vest in three substantially equal annual installments beginning on June 7, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
F6: The Reporting Person was granted RSUs, which each represents a contingent right to receive one share of the Company's Common Stock.
F7: The option vests as to 25% of the underlying shares on March 3, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.
F8: The RSUs vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.